VAQTA SUSPENSION Kanada - İngilizce - Health Canada

vaqta suspension

merck canada inc - hepatitis a vaccine, inactivated - suspension - 50unit - hepatitis a vaccine, inactivated 50unit - vaccines

RABAVERT- rabies vaccine ABD - İngilizce - NLM (National Library of Medicine)

rabavert- rabies vaccine

gsk vaccines gmbh - rabies virus strain flury lep antigen (propiolactone inactivated) (unii: fk894q51ye) (rabies virus strain flury lep antigen (propiolactone inactivated) - unii:fk894q51ye) - rabies virus strain flury lep antigen (propiolactone inactivated) 2.5 [iu] in 1 ml - rabavert is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups. usually, an immunization series is initiated and completed with one vaccine product. no clinical studies have been conducted that document a change in efficacy or the frequency of adverse reactions when the series is completed with a second vaccine product. however, for booster immunization, rabavert was shown to elicit protective antibody level responses in persons tested who received a primary series with hdcv (4,11). (see also dosage and administration section below) preexposure vaccination consists of three doses of rabavert 1.0 ml, intramuscularly (deltoid region), one each on days 0, 7, and 21 or 28 (1) (see also table 1 for criteria for preexposure vaccination). preexposure vaccination does not eliminate the need for additional therapy after a known rabies exposure (see also dosage and administration section, subsection c). preexposure vaccina

LYME HP- baptisia tinctoria, echinacea (angustifolia), hydrastis canadensis, borrelia burgdorferi nosode, encephalitis nosode, m ABD - İngilizce - NLM (National Library of Medicine)

lyme hp- baptisia tinctoria, echinacea (angustifolia), hydrastis canadensis, borrelia burgdorferi nosode, encephalitis nosode, m

energique, inc. - baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinctoria root - unii:5ef0hwi5wu), echinacea angustifolia (unii: vb06av5us8) (echinacea angustifolia - unii:vb06av5us8), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), borrelia burgdorferi (unii: 0j8nv9v5q8) (borrelia burgdorferi - unii:0j8nv9v5q8), japanese encephalitis virus (unii: p07e7xwu9d) (japanese encephalitis virus - unii:p07e7xwu9d), neisseria meningitidis (unii: v3tp2md7f3) (neisseria meningitidis - unii:v3tp2md7f3), hepatitis b - baptisia tinctoria root 3 [hp_x] in 1 ml -  for temporary relief of aches and pains of joints and muscles as a consequence of lyme disease infection.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration. for temporary relief of aches and pains of joints and muscles as a consequence of lyme disease infection.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

RABAVERT- rabies vaccine ABD - İngilizce - NLM (National Library of Medicine)

rabavert- rabies vaccine

a-s medication solutions - rabies virus strain flury lep antigen (propiolactone inactivated) (unii: fk894q51ye) (rabies virus strain flury lep antigen (propiolactone inactivated) - unii:fk894q51ye) - rabies virus strain flury lep antigen (propiolactone inactivated) 2.5 [iu] in 1 ml - rabavert is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups. usually, an immunization series is initiated and completed with one vaccine product. no clinical studies have been conducted that document a change in efficacy or the frequency of adverse reactions when the series is completed with a second vaccine product. however, for booster immunization, rabavert was shown to elicit protective antibody level responses in persons tested who received a primary series with hdcv (4,11). (see also dosage and administration section below) preexposure vaccination consists of three doses of rabavert 1.0 ml, intramuscularly (deltoid region), one each on days 0, 7, and 21 or 28 (1) (see also table 1 for criteria for preexposure vaccination). preexposure vaccination does not eliminate the need for additional therapy after a known rabies exposure (see also dosage and administration section, subsection c). preexposure vaccina

CO-INFXN (babesia microti, bartonella henselae, borrelia burgdorferi nosode, ehrlichia nosode- canine, encephalitis nosode, myco ABD - İngilizce - NLM (National Library of Medicine)

co-infxn (babesia microti, bartonella henselae, borrelia burgdorferi nosode, ehrlichia nosode- canine, encephalitis nosode, myco

deseret biologicals, inc. - babesia microti (unii: 1948x6keg3) (babesia microti - unii:1948x6keg3), bartonella henselae (unii: 84pg7w9845) (bartonella henselae - unii:84pg7w9845), borrelia burgdorferi (unii: 0j8nv9v5q8) (borrelia burgdorferi - unii:0j8nv9v5q8), ehrlichia canis (unii: 970y8t1jzy) (ehrlichia canis - unii:970y8t1jzy), japanese encephalitis virus (unii: p07e7xwu9d) (japanese encephalitis virus - unii:p07e7xwu9d), mycoplasma pneumoniae (unii: jqe470fad0) (mycoplasma pneumoniae - unii:jqe470fad0), neisseria meningitid - babesia microti 15 [hp_x] in 1 ml - for the temporarily relief of symptoms related to lyme disease or other co-infections including joint pain, severe headaches, fever, severe muscle aches/pain, flu-like feelings of headache, stiff neck, muscle aches, and change in smell/taste, difficulty chewing, swallowing or speaking, hoarseness of vocal cord problems.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration. for the temporarily relief of symptoms related to lyme disease or other co-infections including joint pain, severe headaches, fever, severe muscle aches/pain, flu-like feelings of headache, stiff neck, muscle aches, and change in smell/taste, difficulty chewing, swallowing or speaking, hoarseness of vocal cord problems.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

LYME HP- baptisia tinctoria, echinacea (angustifolia), hydrastis canadensis, borrelia burgdorferi nosode, encephalitis nosode, m ABD - İngilizce - NLM (National Library of Medicine)

lyme hp- baptisia tinctoria, echinacea (angustifolia), hydrastis canadensis, borrelia burgdorferi nosode, encephalitis nosode, m

energique, inc. - baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinctoria root - unii:5ef0hwi5wu), echinacea angustifolia (unii: vb06av5us8) (echinacea angustifolia - unii:vb06av5us8), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), borrelia burgdorferi (unii: 0j8nv9v5q8) (borrelia burgdorferi - unii:0j8nv9v5q8), japanese encephalitis virus (unii: p07e7xwu9d) (japanese encephalitis virus - unii:p07e7xwu9d), neisseria meningitidis (unii: v3tp2md7f3) (neisseria meningitidis - unii:v3tp2md7f3), hepatitis b - for temporary relief of aches and pains of joints and muscles as a consequence of lyme disease infection.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration. for temporary relief of aches and pains of joints and muscles as a consequence of lyme disease infection.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

QUADRACEL 0.5mL injection prefilled syringe Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

quadracel 0.5ml injection prefilled syringe

sanofi-aventis australia pty ltd - tetanus toxoid, quantity: 40 iu; pertussis fimbriae 2 + 3, quantity: 5 microgram; diphtheria toxoid, quantity: 30 iu; poliovirus, quantity: 29 dagu; poliovirus, quantity: 26 dagu; poliovirus, quantity: 7 dagu; pertussis toxoid, quantity: 20 microgram; pertactin, quantity: 3 microgram; pertussis filamentous haemagglutinin, quantity: 20 microgram - injection, suspension - excipient ingredients: polymyxin b sulfate; bovine serum albumin; formaldehyde; phenoxyethanol; glutaral; neomycin; water for injections; polysorbate 80; aluminium phosphate - quadracel is indicated for primary immunisation of children from the age of 2 months to 12 months against diphtheria, tetanus, pertussis, and poliomyelitis.,quadracel is also indicated for the fourth dose for children from 15 months to six years of age who have been immunised previously with three doses of diphtheria, tetanus, pertussis and polio vaccines.

JE-VAX 1 DOSE POWDER FOR SUSPENSION Kanada - İngilizce - Health Canada

je-vax 1 dose powder for suspension

(biken) the res.found.for microb.dis.osaka university - japanese encephalitis virus vaccine, inactivated; water - powder for suspension - 1unit; 1.3ml - japanese encephalitis virus vaccine, inactivated 1unit; water 1.3ml - vaccines

Imojev Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

imojev

sanofi-aventis australia pty ltd - japanese encephalitis virus -